PHC Ventures joins Canada’s Delegation to Paris for the Adopt AI Summit

Inside the gilded halls of the Grand Palais in Paris, beneath vaulted glass ceilings that once hosted the first-ever aviation exhibition, a different kind of flight was being charted. Twenty thousand minds converged for Adopt AI—dubbed the “Davos of AI”—where presidents, tech titans, and health care pioneers gathered under the patronage of Emmanuel Macron to answer a singular question: How do we build an AI-powered future that actually works? 

Brian Simmers, President of PHC Ventures and CFO of Providence Health Care, attended as part of a small Canadian delegation organized by DIGITAL. Other Canadian participants included Dova Health Intelligence, ACTO, ORX, Medtronic, Excelar, and 3D Bridge Solutions Inc. The keynotes and panel discussions explored what AI means for healthcare—one of humanity’s most critical systems. 

The conversations weren’t theoretical, they were urgent. How do we move from pilot projects to system-wide transformation? How do we ensure AI serves patients, not just balance sheets? And crucially—how do we do this responsibly, at scale, right now? 

These aren’t abstract questions for PHC Ventures. They’re the operating principles behind every partnership, every investment, every bet on what health care could become. 

“AI in health care isn’t just about technology—it’s about trust, context, and people,” explains Brian Simmers. “Success comes when innovation is embedded within patient data rules, local insights drive accuracy, and teams are empowered through change management. Strategic partnerships and outcome-based incentives will turn AI’s promise into real-world impact for patients.” 

Consider the work already underway 

PHC Ventures most recent partnerships in AI solutions are a glimpse at what the future may hold.  As a for-profit subsidiary, PHC Ventures reinvests its returns into Providence Health Care, fueling research and innovation that directly benefit patients.  

Ventripoint Diagnostics is validating AI-enhanced echocardiography that could slash MRI wait times and get cardiac patients answers faster—potentially saving lives measured in hours, not weeks. 

Through VuesML, tissue analysis that once crawled along for weeks now races to completion in days. Virtual staining powered by AI is collapsing research timelines and opening new pathways for patient care that were previously bottlenecked by outdated processes. 

And with Kakao Healthcare Corp, the focus shifts to something even more foundational: privacy-first AI development, federated learning, and global data standards that make secure, scalable digital health not just possible, but inevitable. 

PHC Ventures’ Commercialization Pathway Program accelerates the progress of Canadian health innovators, helping them reach key development and commercialization milestones faster while leveraging our global network to open expedited access to EU and Asia-Pacific markets. 

This isn’t innovation for innovation’s sake. It’s a deliberate strategy to position Providence Health Care at the leading edge of technological transformation; where breakthroughs happen, where new models emerge, where the future gets built. 

The organizations that will define the next era of health care are showing up, engaging, investing, and building right now, in real time. PHC Ventures is making a clear statement: They’re not watching this transformation unfold, they are helping write it.